Dostar LB 100 study
JavaScript is disabled in your browser. Please enable JavaScript for a better experience.
SP
Safety and efficacy of targeting PP2A in ovarian clear cell carcinoma using Dostarlimab and LB-100
Study Details
Find more information here
If you or someone you know is battling cancer, discover how Dostarlimab can be an effective treatment option
Contact us
Interested in participating in the study?
Send us an e-mail
close
chevron-down
bars
